PVG.L Regulatory News (PVG)

EXERCISE OF OPTIONS AND WARRANTS

DIRECTOR'S DEALING

TOTAL VOTING RIGHTS

BLOCK LISTING APPLICATION

Exercise of options and warrants

London, 21 June 2016: Premier Veterinary Group plc (LSE: PVG) (the "Company") announces that it has received notices of exercise of options under the Company's Enterprise Management Incentive Share Option Plan (the "EMI Plan") from certain employees and a Director of the Company (the "Option Exercise") to subscribe for a total of 816,143 new ordinary shares of 10 pence each in the Company (the "New Ordinary Shares"). The exercise price of the options is 10.1 pence each.

In addition, the Company has received notice of exercise of warrants from WG Partners LLP to subscribe for 139,517 New Ordinary Shares at a price of 10.1 pence per share. Warrants over 279,034 ordinary shares of 10 pence each were granted to WG Partners LLP as part of the arrangements relating to the reverse acquisition by the Company of Premier Veterinary Group Limited (now PVG 2007 Limited) completed in February 2015. The balance of the warrants will vest and become exercisable with effect from 27 February 2017.

Application has been made to the London Stock Exchange for the admission of a total of 955,660 New Ordinary Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). Admission is expected to occur on or around 23 June 2016. The New Ordinary Shares will rank pari passu with the existing ordinary shares in the Company.

Directors' dealings

Included in the above total of 816,143 share options are 209,277 options which were exercised by Daniel Smith, a Director of the Company.

Following the exercise of these options, Daniel Smith owns 209,277 ordinary shares, representing approximately 1.4% of the Company's enlarged issued share capital. Mr Smith holds no further share options.

Total voting rights

Following Admission, the Company's enlarged issued share capital will comprise 14,907,433 ordinary shares. The Company does not hold any shares in treasury. The figure of 14,907,433 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Block Listing Application

The Company further announces that is has made a block listing application to the London Stock Exchange for the admission of up to 579,035 ordinary shares of 10 pence each to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities.

The block listing application relates to 579,035 shares, being the total number of shares that could be issued pursuant to the exercise of all options currently outstanding under the EMI Plan. If all the options were exercised, the shares that would be issued would represent approximately 3.88% of the enlarged issued share capital.

The application for the admission of these shares has been made in advance for ease of administration as all the outstanding options under the EMI Plan vested and became exercisable on 27 February 2016.

Shares issued pursuant to the exercise of options under the EMI Plan will rank pari passu with the existing ordinary shares of 10 pence each in the share capital of the Company.

It is expected that the block admission will become effective on 23 June 2016.

Enquiries:

Premier Veterinary Group plc

Sue Steven, Company Secretary +44 (0)117 370 0300